“It has reached a point where we felt we had to step back and take a careful look at everything and see what we could do,” said Dr. Robert Califf, the acting commissioner and nominee to run the agency. “We thought we could do more.”
The measures include:
- Holding expert panels before approving some new opioids.
- Strengthening requirements research approved drugs.
- Expanding access to pain management training for doctors.
“What I’m seeing here is the F.D.A. attempting to say something in response to congressional concerns, perhaps in response to the holdup of approval of the new F.D.A. commissioner, without actually having any vision for change,” said Dr. Nathaniel Katz, an assistant professor of anesthesia at Tufts University School of Medicine in Boston.
Whether the FDA’s intentions are well meaning is not important, what is important is that moves are being made to mitigate the crisis we face as a nation. People are suffering and they have limited options for receiving the help they desperately need. If you or a loved one is struggling with opioid addiction, please contact Cottonwood Tucson. We can help you begin the journey of recovery.